share_log

YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | SC 13G: Statement of acquisition of beneficial ownership by individuals-Yi ZHANG(42.6%),All Brilliance Investments Limited(41.9%), etc.

YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | SC 13G: Statement of acquisition of beneficial ownership by individuals-Yi ZHANG(42.6%),All Brilliance Investments Limited(41.9%), etc.

YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | SC 13G:超過5%持股股東披露文件-Yi ZHANG(42.6%),All Brilliance Investments Limited(41.9%)等
美股sec公告 ·  02/15 16:30
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息